About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Kyowa Kirin Co., Ltd.(4151) Summary

4151
TSE Prime
Kyowa Kirin Co., Ltd.
2,320.0
JPY
+6.0
(+0.26%)
Jan 9, 3:30 pm JST
14.67
USD
Jan 9, 1:30 am EST
Result
PTS
outside of trading hours
2,310.7
Jan 9, 9:53 pm JST
Summary Chart Historical News Financial Result
PER
17.8
PBR
1.45
Yield
2.50%
Margin Trading Ratio
33.62
Stock Price
Jan 9, 2025
Opening Jan 9, 9:00 am
2,307.0 JPY 14.58 USD
Previous Close Jan 8
2,314.0 JPY 14.64 USD
High Jan 9, 3:09 pm
2,330.0 JPY 14.73 USD
Low Jan 9, 10:58 am
2,296.5 JPY 14.52 USD
Volume
877,200
Trading Value
2.03B JPY 0.01B USD
VWAP
2314.27 JPY 14.64 USD
Minimum Trading Value
232,000 JPY 1,467 USD
Market Cap
1.22T JPY 7.72B USD
Number of Trades
1,984
Liquidity & Number of Trades
As of Jan 9, 2025
Liquidity
High
1-Year Average
2,866
1-Year High Sep 25, 2024
21,616
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 27, 2024 20,800 534,900 25.72
Dec 20, 2024 32,700 568,500 17.39
Dec 13, 2024 26,200 598,200 22.83
Dec 6, 2024 25,600 552,300 21.57
Nov 29, 2024 23,600 562,500 23.83
Company Profile
Kyowa Kirin Co., Ltd. is a subsidiary of Kirin Group, focusing on pharmaceutical business and new drug development through its biotechnology division. The company has formed a partnership with Fujifilm.
Sector
Pharmaceuticals
Kyowa Kirin Co., Ltd. primarily engages in the manufacture and sale of prescription pharmaceuticals. The company has numerous subsidiaries and equity-method affiliates, with Kirin Holdings as its parent company. Kyowa Kirin operates globally, with a particular focus on four key markets: Japan, North America, Europe, and Asia-Oceania. The company excels in biopharmaceutical development, possessing a unique drug discovery platform centered on antibody drug development and manufacturing technologies. Kyowa Kirin concentrates on creating new drugs that address unmet medical needs, particularly in disease areas such as nephrology, oncology, and immunology-allergy.